GKB OPHTHALMICS LTD.

NSE : NABSE : 533212ISIN CODE : INE265D01015Industry : Medical Equipment/Supplies/AccessoriesHouse : GKB
BSE113.67-0.64 (-0.56 %)
PREV CLOSE ( ) 114.31
OPEN PRICE ( ) 111.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 28992
TODAY'S LOW / HIGH ( )111.00 113.93
52 WK LOW / HIGH ( ) 74.1127.95
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax1.3919.46-9.29-18.40-15.79
Adjustment38.8835.1833.0249.5039.65
Changes In working Capital-66.37-3.2045.171.6615.64
Cash Flow after changes in Working Capital-26.0951.4468.9132.7639.50
Cash Flow from Operating Activities-27.7450.6968.5632.6639.18
Cash Flow from Investing Activities14.29-35.25-167.75-37.25-98.93
Cash Flow from Financing Activities-21.85-16.6427.6742.99131.34
Net Cash Inflow / Outflow-35.30-1.20-71.5238.3971.59
Opening Cash & Cash Equivalents58.9460.14131.6693.2721.68
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent23.6458.9460.14131.6693.27

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.